Top Markets
#1 Akedo Akedo +136.52%
#2 TENDIES TENDIES +87.88%
#3 Verus Coin Verus Coin +43.84%
#4 Threshold Network Threshold Network +43.74%
#5 Bitway Bitway +27.02%
#6 Mubarak Mubarak +25.52%
#7 Cash Cat Cash Cat +23.53%
#8 Palladium Network Palladium Network +22.71%
#9 MultiversX MultiversX +20.20%
#10 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
Coin of the day
Akedo Akedo
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Regulus Therapeutics Inc. Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
Classifica tra le azioni #17600
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development... Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compound engineered to inhibit miR-21, which is currently in a Phase II clinical study for Alport syndrome, a severe renal condition. Another significant candidate, RGLS8429, an anti-miR agent targeting miR-17, is being evaluated in a Phase 1b clinical trial for autosomal dominant polycystic kidney disease. Beyond these clinical programs, Regulus is also cultivating an extensive preclinical portfolio, emphasizing drug candidates with precise, organ-selective delivery strategies. The company was established in 2007.
Prezzo delle azioni
$8.16
Ultima sincronizzazione: 2025-06-26
Capitalizzazione di mercato
$234.57M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Regulus Therapeutics Inc. (RGLS)

Categoria

Healthcare
Storico del prezzo dell'azione per Regulus Therapeutics Inc. (RGLS)
Prezzo di chiusura più alto: $8.13 il 2025-06-01

Prezzo di chiusura più basso: $542.40 il 2012-10-01
Storico del prezzo dell'azione di Regulus Therapeutics Inc. dal 2012 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2025 412.85%
2024 18.41%
2023 -5.90%
2022 -59.58%
2021 -68.07%
2020 52.53%
2019 -42.38%
2018 -88.97%
2017 -61.61%
2016 -73.01%
2015 -43.68%
2014 142.24%
2013 35.08%
2012 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $556.43 38.76%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.60%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $152.82 531.75%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 8.20%
CH